Christopher Bland is an accomplished oncology expert with over 15 years of experience in the industry. He has a strong background in research and clinical operations, having worked in highly matrixed, cross-functional environments. Bland has expertise in drug launch, KOL engagement/mapping, business development, and alliance management. He has also spearheaded several successful clinical development and pre-clinical oncology research projects in the past.

Bland holds a Doctor of Philosophy (Ph.D.) in Cell and Molecular Biology-cancer track from Baylor College of Medicine, an MBA in Health/Health Care Administration/Management from Duke University, and a Bachelor's degree in Microbiology and Biology from the University of Texas at El Paso.

Over the years, Bland has worked as a Senior Medical Director, Oncology at Pfizer, Global Director of External Medical Engagement, Oncology at GSK, Principal Medical Science Liaison, and Solid Tumor Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson, among other leadership roles in the industry. He has also served as an Adjunct Professor at the University of Houston, sharing his expertise with budding scientists and researchers.